Houston, TX
United States
University of Texas at Houston - Department of Leukemia
myelodysplastic syndromes, MDS, oral decitabine, venetoclax, chronic myelomonocytic leukemia, CMML
Philadelphia-negative ALL, inotuzumab, blinatumomab, chemo-immunotherapy, salvage, outcome